Spero 宣布 GSK 向 FDA 重新提交 Tebipenem Hbr 的 NDA 用于治疗复杂性尿路感染,包括肾盂肾炎

美股速递
Dec 19, 2025

Spero 宣布 GSK 向 FDA 重新提交 Tebipenem Hbr 的 NDA,用于治疗复杂性尿路感染,包括肾盂肾炎。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10